Pharma Journalist -

PharmaJet announced that its Needle-free Injection System technology will be used to deliver a messenger RNA (mRNA) vaccine against SARS-CoV-2. The vaccine is being developed by Abnova…
Read More...

SMi Reports: The 2nd Annual Next Generation Pharmaceutical Cleanroom Conference will convene in London on 7th – 8th October 2020. Following on from the success of last years…
Read More...

AveXis, a Novartis company, announced the European Commission (EC) granted conditional approval for Zolgensma (onasemnogene abeparvovec) for the treatment of patients with 5q spinal…
Read More...

Phlow, a U.S.-based, public benefit drug manufacturing corporation, has received federal government funding of $354 million for advanced manufacturing of America's most essential…
Read More...

Vividion Therapeutics, a biotechnology company discovering and developing highly selective small molecule medicines that drug traditionally inaccessible targets, today announced that it…
Read More...

Starts NEXT WEEK - May 25th-30th! Join 40+ great speakers from 25+ countries sharing timely insights and case studies about healthcare transformation and current digital healthcare…
Read More...

Moderna, Inc. a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced results from the Phase 1 CHRYSALIS study evaluating amivantamab (JNJ-6372) in the treatment of patients with…
Read More...

SMi Reports: SMi Group are delighted to announce that Jace Blackburn, Smart Device Engineer, Genentech will be a speaker at the inaugural Pre-filled Syringes San Francisco Conference on…
Read More...

Innovent Biologics, Inc. and The University of Texas MD Anderson Cancer Center announced a strategic collaboration agreement to co-develop TYVYT (sintilimab injection), Innovent's…
Read More...